NCT02393248 Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) Status TERMINATED Phase PHASE1/PHASE2
NCT02379429 Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue Status RECRUITING Phase N/A
NCT02365597 An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02335424 Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-052) Status COMPLETED Phase PHASE2
NCT02256436 A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045) Status COMPLETED Phase PHASE3
NCT02111850 T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive Status COMPLETED Phase PHASE1/PHASE2
NCT02052778 A Study of TAS-120 in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT02033993 Nab-Paclitaxel to Paclitaxel in Advanced Urothelial Cancer Progressing on or After Platinum Containing Regimen. Status COMPLETED Phase PHASE2
NCT01801137 The Efficacy of RAD 001 as Second Line Therapy in Patients With Transitional Cell Carcinoma TCC of the Urothelium Status COMPLETED Phase PHASE2
NCT01700010 Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial Cancer Status WITHDRAWN Phase PHASE2
NCT01663285 Clinical Trial Of Neoadjuvant Chemotherapy (NAC)In Upper Tract Urothelial Carcinoma (UTUC) Status TERMINATED Phase PHASE2
NCT01206426 Genetic Determinants of Response to Neoadjuvant Cisplatin-based Chemotherapy in Urothelial Cancer Status COMPLETED Phase N/A
NCT00995488 Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial Cancer Status TERMINATED Phase PHASE2
NCT00872495 Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer Status RECRUITING Phase N/A
NCT00578526 SU011248 for Platinum-Refractory Urothelial Cancer Evaluation Trial Status COMPLETED Phase PHASE2